Search





Search





Markets
/
Stocks
/
sln
/

Silence Therapeutics PLC

SLN

Add to Watchlist

10.490USD

-1.130-9.72%

Close 07-31 16:00（ET）Quotes delayed by 15 min

495.49MMarket Cap

LossP/E TTM

Silence Therapeutics PLC

10.490

-1.130-9.72%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

SLN Cash Flow Statement

You can access the annual and quarterly cash flow statements of Silence Therapeutics PLC to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q1

FY2021H2

FY2021H1

FY2020H2

FY2020H1

FY2019H2

FY2019H1

FY2018H2

FY2018H1

FY2017H2

FY2017H1

FY2016H2

FY2016H1

FY2015H2

FY2015H1

FY2014H2

FY2014H1

FY2013H2

FY2013H1

FY2012H2

FY2012H1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-26.76%-15.60M

---17.29M

56.36%-10.89M

-311.26%-21.78M

-36.93%-12.31M

-355.92%-24.96M

71.94%-5.30M

1.25%-8.99M

---14.25M

---5.47M

---18.88M

52.78%-9.10M

---19.28M

35.60%-9.71M

1607.60%19.34M

-200.04%-15.08M

108.55%1.13M

246.37%15.07M

-9.96%-13.25M

-49.20%-10.30M

-118.77%-12.05M

-30.86%-6.90M

33.42%-5.51M

-3.02%-5.27M

-14.53%-8.27M

23.25%-5.12M

16.98%-7.22M

-449.97%-6.67M

28.86%-8.70M

154.68%1.91M

-190.17%-12.23M

---3.48M

---4.21M

Net income from continuing operations

47.57%-14.96M

---11.77M

46.55%-20.96M

-24.33%-27.35M

-568.54%-28.53M

-190.67%-39.21M

-46.40%-22.00M

72.27%-4.27M

---18.58M

---13.49M

---15.03M

-19.90%-15.39M

---12.84M

-6.97%-31.72M

-86.54%-31.32M

-77.42%-29.66M

-35.30%-16.79M

-20.27%-16.71M

7.75%-12.41M

-466.02%-13.90M

-60.67%-13.45M

152.84%3.80M

-5.39%-8.37M

11.33%-7.19M

-25.92%-7.94M

21.50%-8.10M

32.77%-6.31M

-16.46%-10.32M

-78.43%-9.38M

-101.79%-8.86M

85.82%-5.26M

---4.39M

---37.09M

Operating gains losses

-23.19%106.00K

--113.00K

4.33%156.00K

-1.41%148.00K

-9.32%138.00K

-5.47%149.52K

1.67%150.12K

-6.49%152.18K

--150.20K

--158.17K

--147.65K

7.39%162.74K

--151.55K

-34.86%239.84K

29.16%348.22K

29.94%368.21K

-18.88%269.59K

6.29%283.36K

25.27%332.32K

-13.92%266.58K

6.51%265.29K

42.72%309.70K

24.11%249.07K

26.43%217.00K

88.17%200.68K

-52.18%171.63K

-42.42%106.65K

92.04%358.94K

-32.99%185.22K

255.62%186.91K

-99.15%276.41K

--52.56K

--32.64M

Other non-cash items

-126.52%-544.00K

---650.00K

-76.15%-1.69M

73097.30%17.54M

1115.98%2.05M

-227.06%-958.26K

-93.86%23.97K

65.33%168.67K

---1.76M

--754.18K

--390.40K

-33.27%102.02K

--152.89K

-90.56%415.64K

--0.00

--4.40M

----

100.00%0.00

--0.00

-229.27%-1.77M

----

41.83%1.37M

----

567.30%963.90K

-248.40%-958.32K

-143.85%-206.27K

3701.78%645.78K

852.83%470.45K

977.40%16.99K

--49.37K

--1.58K

Change in working capital

-125.30%-2.65M

---4.89M

1319.63%9.06M

-210.73%-14.22M

152.78%10.49M

-86.26%638.41K

248.11%12.84M

-125.08%-19.88M

--1.80M

--4.65M

---8.67M

15.09%-8.83M

---10.40M

2166.05%9.76M

159.14%43.95M

-98.45%430.89K

1480.67%16.96M

5695.68%27.75M

-264.58%-1.23M

249.51%478.81K

-69.63%746.40K

68.00%-320.25K

599.89%2.46M

6.44%-1.00M

154.24%351.20K

-163.14%-1.07M

60.84%-647.51K

-80.09%1.69M

79.59%-1.65M

12524.72%8.51M

-9444.01%-8.10M

---68.49K

--86.71K

-Change in receivables

-102.25%-209.00K

--220.00K

-234.75%-2.43M

-216.82%-9.28M

192.47%9.28M

-87.98%1.80M

157.69%7.94M

-961.94%-10.03M

--290.48K

--15.01M

---13.77M

68.59%-944.88K

---3.01M

-139.92%-1.89M

196.56%40.05M

93955.78%4.73M

---41.48M

-100.36%-5.04K

100.00%0.00

913.82%1.42M

-155.32%-553.96K

85.06%-173.96K

691.98%1.00M

-253.34%-1.16M

-754.02%-169.15K

-142.17%-329.47K

97.61%-19.81K

-90.05%781.23K

89.63%-827.66K

13794.17%7.85M

-9652.46%-7.98M

---57.34K

--83.56K

-Change in inventory

----

--0.00

-Change in payables and accrued expense

-259.58%-2.95M

---3.58M

433.93%2.88M

-189.48%-5.23M

168.86%1.85M

-825.82%-863.34K

481.22%5.85M

-627.34%-2.68M

--939.70K

--118.95K

---1.53M

112.24%508.87K

---4.16M

-18.19%3.72M

83.66%-448.11K

-13.23%4.54M

-92.81%-2.74M

1923.24%5.24M

-209.38%-1.42M

276.93%258.82K

-10.73%1.30M

-189.53%-146.29K

179.95%1.46M

122.07%163.39K

182.90%520.35K

-181.09%-740.16K

24.01%-627.71K

38.85%912.79K

-585.77%-826.00K

5996.16%657.37K

-3919.88%-120.45K

---11.15K

--3.15K

-Change in other current assets

285.09%931.00K

---1.48M

2449.44%8.72M

120.00%503.00K

69.23%-503.00K

104.45%341.96K

-233.13%-2.52M

-200.98%-1.63M

--2.57M

---7.69M

--1.89M

275.97%1.62M

---920.00K

21.55%-2.61M

333.49%3.47M

-2259.63%-3.33M

-867.06%-1.49M

88.20%-141.05K

--193.96K

---1.20M

----

-Change in other current liabilities

-461.11%-404.00K

---32.00K

86.33%-88.00K

-109.08%-142.00K

98.70%-72.00K

76.99%-643.61K

-67.02%1.56M

44.81%-5.53M

---2.00M

---2.80M

--4.74M

-332.15%-10.01M

---2.32M

291.28%10.54M

-98.60%875.41K

-124.33%-5.51M

--62.67M

--22.66M

----

Cash from non-recurring investing activities

Cash from operating activities

-26.76%-15.60M

---17.29M

56.36%-10.89M

-311.26%-21.78M

-36.93%-12.31M

-355.92%-24.96M

71.94%-5.30M

1.25%-8.99M

---14.25M

---5.47M

---18.88M

52.78%-9.10M

---19.28M

35.60%-9.71M

1607.60%19.34M

-200.04%-15.08M

108.55%1.13M

246.37%15.07M

-9.96%-13.25M

-49.20%-10.30M

-118.77%-12.05M

-30.86%-6.90M

33.42%-5.51M

-3.02%-5.27M

-14.53%-8.27M

23.25%-5.12M

16.98%-7.22M

-449.97%-6.67M

28.86%-8.70M

154.68%1.91M

-190.17%-12.23M

---3.48M

---4.21M

Investing cash flow

Net cash from continuing investing activities

-100.00%0.00

--0.00

-100.00%3.00K

-43.21%48.00K

-99.99%4.00K

227434.41%63.34M

-99.67%84.52K

124696.96%50.02M

--1.24K

--27.84K

--25.85M

-43.61%40.08K

--71.08K

706.56%1.20M

25.66%628.46K

2854.86%148.85K

7635.59%500.14K

-97.93%5.04K

--6.47K

235.64%243.29K

-100.00%0.00

-88.24%72.48K

91.76%148.44K

-45.19%616.54K

-56.20%77.41K

149.11%1.12M

76.52%176.73K

203.24%451.52K

47.36%100.12K

-5.57%148.90K

-51.03%67.94K

--157.68K

--138.74K

Capital expenditures

-100.00%0.00

--0.00

-100.00%3.00K

-43.21%48.00K

-99.99%4.00K

227434.41%63.34M

-99.67%84.52K

124696.96%50.02M

--1.24K

--27.84K

--25.86M

-43.61%40.08K

--71.08K

685.88%1.20M

25.66%628.46K

2932.62%152.77K

7635.59%500.14K

-97.93%5.04K

--6.47K

235.64%243.29K

-100.00%0.00

-88.24%72.48K

91.76%148.44K

-45.19%616.54K

-56.20%77.41K

149.11%1.12M

76.52%176.73K

203.24%451.52K

47.36%100.12K

-5.57%148.90K

-58.56%67.94K

--157.68K

--163.97K

Net cash flow from disposal of fixed assets

-100.00%0.00

--0.00

-95.29%3.00K

-43.21%48.00K

--4.00K

151.74%63.71K

2351.54%84.52K

-100.00%0.00

--1.24K

--25.31K

---3.75K

-53.87%32.79K

--71.08K

685.50%1.17M

26.62%628.46K

2854.86%148.85K

7577.13%496.36K

-97.01%5.04K

--6.47K

132.09%168.23K

-100.00%0.00

-87.18%72.48K

111.33%148.44K

-49.38%565.48K

-59.56%70.24K

147.42%1.12M

76.42%173.69K

206.50%451.52K

136.13%98.45K

2212.29%147.31K

265.28%41.69K

--6.37K

---25.23K

Net cash flow from intangible asset transactions

----

2500261.06%63.28M

-100.00%0.00

686283.26%50.02M

--0.00

--2.53K

--25.85M

--7.29K

----

--31.34K

-100.00%0.00

--0.00

--3.78K

-100.00%0.00

--0.00

--75.06K

----

-100.00%0.00

566.38%51.06K

135.22%7.17K

--7.66K

82.61%3.05K

-100.00%0.00

-93.64%1.67K

-98.95%1.58K

-83.99%26.25K

--151.31K

--163.97K

Net cash flow from investment products

----

-0.77%25.24M

----

--0.00

--25.44M

--20.12M

--0.00

----

-65.24%13.62M

100.01%2.77K

307.50%39.20M

---25.22M

---18.89M

100.00%0.00

-100.00%0.00

-3.92%-6.43M

535.24%23.88M

---6.19M

---5.49M

-100.00%0.00

--0.00

--7.62M

100.00%0.00

--0.00

-12850.42%-7.92M

--0.00

--62.12K

--0.00

Net cash flow from other investing activities

122.53%10.00M

---53.34M

--51.29M

---1.51M

---44.38M

----

--355.16K

---342.66K

----

---1.29K

----

--0.00

---62.12K

----

Cash from non-current investing activities

Net cash flow from investing activities

122.53%10.00M

---53.34M

234.62%51.29M

-1748.10%-1.56M

11.27%-44.38M

-249.93%-38.10M

98.52%-84.52K

-124696.96%-50.02M

---1.24K

--25.41M

---5.73M

43.61%-40.08K

---71.08K

-68.47%12.42M

97.60%-625.69K

308.54%39.41M

-403046.76%-26.07M

-7625.71%-18.90M

99.90%-6.47K

-101.03%-244.58K

-1.49%-6.43M

490.09%23.81M

-8088.86%-6.34M

-442.68%-6.10M

-101.04%-77.41K

-149.11%-1.12M

7532.09%7.44M

94.40%-451.52K

-47.36%-100.12K

-5017.32%-8.07M

12.05%-67.94K

---157.68K

---77.25K

Financing cash flow

Cash flow from continuous financing activities

-100.00%0.00

--0.00

-100.00%0.00

-99.91%1.00K

-99.99%14.00K

-49.03%7.76M

-73.18%1.07M

580068.67%133.88M

--12.31M

--15.23M

--3.98M

136.61%23.08K

---63.03K

217.34%579.17K

111.01%42.02M

-107.73%-493.56K

7599.54%19.91M

1874.78%6.39M

106.75%258.62K

--323.52K

107.16%125.09K

100.00%0.00

--60.38K

-8313.08%-128.92K

-100.00%0.00

-115.73%-1.53K

229.85%59.65M

-90.54%9.75K

-37.43%18.09M

-99.37%102.96K

--28.91M

--16.32M

--0.00

Net cash flow from debt Issuance/repayment

----

-2.75%-63.71K

-187.62%-122.36K

100.00%0.00

---53.38K

---62.00K

---42.54K

7.51%-58.30K

---63.03K

205.15%551.91K

---854.60K

---524.90K

----

--0.00

Net cash flow from common stock issuance/repurchase

-100.00%0.00

--0.00

-100.00%0.00

-99.92%1.00K

-99.99%14.00K

-46.09%8.24M

-70.43%1.19M

174626.07%142.18M

--12.37M

--15.29M

--4.03M

--81.37K

--0.00

-13.03%27.26K

115.30%42.87M

-99.51%31.34K

7599.54%19.91M

1874.78%6.39M

106.75%258.62K

--323.52K

107.16%125.09K

--0.00

--60.38K

100.00%0.00

-100.00%0.00

-115.73%-1.53K

229.85%59.65M

-90.54%9.75K

-37.43%18.09M

-99.37%102.96K

--28.91M

--16.32M

--0.00

Proceeds from stock option exercised by employees

----

100.00%0.00

--0.00

---128.92K

--0.00

----

Net cash flow from other financing activities

----

---418.67K

--0.00

---8.30M

----

Net cash from non-recurrent financing activities

Net cash from financing activities

-100.00%0.00

--0.00

-100.00%0.00

-99.91%1.00K

-99.99%14.00K

-49.03%7.76M

-73.18%1.07M

580068.67%133.88M

--12.31M

--15.23M

--3.98M

136.61%23.08K

---63.03K

217.34%579.17K

111.01%42.02M

-107.73%-493.56K

7599.54%19.91M

1874.78%6.39M

106.75%258.62K

--323.52K

107.16%125.09K

100.00%0.00

--60.38K

-8313.08%-128.92K

-100.00%0.00

-115.73%-1.53K

229.85%59.65M

-90.54%9.75K

-37.43%18.09M

-99.37%102.96K

--28.91M

--16.32M

--0.00

Net cash flow

Beginning cash balance

-90.71%11.28M

--82.03M

-71.49%41.74M

-54.60%64.89M

77.89%121.33M

303.81%146.38M

140.75%142.93M

0.89%68.20M

--74.86M

--36.25M

--59.37M

-30.00%67.60M

--96.58M

582.89%96.38M

126.49%37.95M

-7.53%14.11M

-38.58%16.76M

-59.22%15.26M

-51.67%27.28M

-7.21%37.42M

11.10%56.45M

-31.30%40.33M

-26.43%50.81M

-28.57%58.71M

160.89%69.07M

147.76%82.19M

-2.59%26.47M

1.62%33.17M

100.56%27.18M

2012.32%32.65M

133.95%13.55M

--1.55M

--5.79M

Current period cash flow changes

90.04%-5.62M

---70.75M

165.20%40.29M

-413.41%-23.15M

-175.40%-56.44M

-267.87%-61.80M

78.82%-4.51M

862.34%74.86M

---5.93M

--36.81M

---21.29M

48.59%-9.82M

---19.10M

-85.99%3.13M

1610.25%60.75M

786.09%22.36M

68.84%-4.02M

124.87%2.52M

29.96%-12.91M

-159.71%-10.15M

-59.91%-18.43M

255.14%17.00M

-86.44%-11.53M

-85.15%-10.95M

-110.43%-6.18M

18.05%-5.92M

556.45%59.28M

-19.06%-7.22M

-45.89%9.03M

-147.84%-6.06M

486.67%16.69M

--12.67M

---4.32M

Effect of exchange rate changes

-107.33%-17.00K

---129.00K

98.37%-106.00K

201.26%198.00K

1624.47%232.00K

-493.99%-6.50M

70.57%-195.53K

97.82%-15.22K

---3.99M

--1.65M

---664.43K

-324.84%-699.55K

--311.14K

88.99%-162.17K

-98.05%19.42K

-3672.59%-1.47M

1051.66%997.75K

-156.92%-39.04K

214.60%86.64K

-18.68%68.59K

-129.17%-75.60K

-84.70%84.35K

-88.04%259.14K

68.15%551.44K

467.35%2.17M

401.36%327.94K

-130.94%-589.62K

-3334.93%-108.82K

-411.95%-255.31K

33.70%-3.17K

424.44%81.84K

---4.78K

---25.23K

Ending cash balance

-91.28%5.66M

--11.28M

-0.97%82.03M

-69.84%41.74M

-54.53%64.89M

15.47%82.83M

266.58%138.41M

147.62%142.71M

--68.78M

--71.73M

--37.76M

-25.99%57.63M

--77.87M

165.08%99.49M

669.65%98.50M

109.44%37.53M

-12.41%12.80M

-34.65%17.92M

-62.29%14.61M

-52.53%27.42M

-0.35%38.74M

20.02%57.76M

-38.61%38.88M

-37.09%48.12M

-27.69%63.33M

191.42%76.50M

140.40%87.58M

-0.21%26.25M

21.48%36.43M

81.71%26.31M

1910.17%29.99M

--14.48M

--1.49M

Free cash flow

-26.72%-15.60M

---17.29M

87.66%-10.89M

-305.69%-21.83M

79.13%-12.31M

-1504.89%-88.30M

87.97%-5.38M

-545.38%-59.01M

---14.26M

---5.50M

---44.74M

52.75%-9.14M

---19.35M

28.37%-10.91M

2858.66%18.71M

-201.09%-15.23M

104.77%632.41K

242.94%15.06M

-10.01%-13.25M

-51.14%-10.54M

-113.03%-12.05M

-18.39%-6.97M

32.25%-5.66M

5.66%-5.89M

-12.84%-8.35M

12.32%-6.24M

15.92%-7.40M

-505.33%-7.12M

28.44%-8.80M

148.23%1.76M

-180.86%-12.30M

---3.64M

---4.38M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Silence Therapeutics PLC Generate?



Silence Therapeutics PLC generated -62.27M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Silence Therapeutics PLC's Operating Cash Flow Change Year Over Year?



Silence Therapeutics PLC's operating cash flow increased by 7.94% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Silence Therapeutics PLC Spend on Capital Expenditures?



Silence Therapeutics PLC spent 55.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Silence Therapeutics PLC's Financing Cash Flow Changed?



Silence Therapeutics PLC used 15.00K in financing activities in the latest quarter.

What is free cash flow and why does it matter for SLN?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Silence Therapeutics PLC’s free cash flow in the latest quarter?



Free cash flow was -62.33M reflecting a 8.14% change from the previous year.